Mingcheng Yuan

Finding the optimal regimen for short-term daily recombinant human erythropoietin treatment for blood-saving purpose in patients undergoing unilateral primary total hip arthroplasty: a double-blinded randomized placebo-controlled trial

2022 · 7 Zit. · BMC Musculoskeletal Disorders

Optimization of the Dosing Schedule of Recombinant Human Erythropoietin for Perioperative Autologous Blood Donation in Patients undergoing Total Knee Arthroplasty

2023 · 1 Zit.

Finding the Optimal Regimen for Short-Term Daily Recombinant Human Erythropoietin Treatment for Blood-Saving Purpose in Patients undergoing Unilateral Primary Total Hip Arthroplasty: A Double-Blinded Randomized Placebo-Controlled Trial

2021 · 0 Zit. · Research Square